RAYMOND JAMES & ASSOCIATES - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 215 filers reported holding CORCEPT THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 1.10 and the average weighting 0.2%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$850,000
+11.0%
33,149
+3.0%
0.00%0.0%
Q2 2022$766,000
-58.3%
32,198
-54.2%
0.00%
-50.0%
Q4 2020$1,838,000
+33.4%
70,264
-11.2%
0.00%0.0%
Q3 2020$1,378,000
-6.7%
79,166
-9.9%
0.00%0.0%
Q2 2020$1,477,000
+11.4%
87,831
-21.3%
0.00%0.0%
Q1 2020$1,326,000
-44.6%
111,532
-43.6%
0.00%
-33.3%
Q4 2019$2,392,000
+0.2%
197,664
+17.1%
0.00%0.0%
Q3 2019$2,387,000
+22.9%
168,857
-3.1%
0.00%0.0%
Q2 2019$1,943,000
+31.6%
174,259
+38.5%
0.00%
+50.0%
Q1 2019$1,477,000
-39.4%
125,781
-31.1%
0.00%
-50.0%
Q4 2018$2,438,000
+152.1%
182,520
+164.6%
0.00%
+300.0%
Q3 2018$967,000
+23.8%
68,977
+38.9%
0.00%0.0%
Q2 2018$781,000
+14.7%
49,670
+20.1%
0.00%0.0%
Q1 2018$681,000
-5.4%
41,368
+3.8%
0.00%0.0%
Q4 2017$720,000
-60.6%
39,863
-57.9%
0.00%
-75.0%
Q3 2017$1,829,000
+76.0%
94,748
+7.6%
0.00%
+100.0%
Q2 2017$1,039,000
+108.6%
88,028
+93.9%
0.00%
+100.0%
Q1 2017$498,00045,4000.00%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 8,003,723$95,164,0006.41%
TANAKA CAPITAL MANAGEMENT INC 65,609$780,0003.41%
S&T BANK/PA 588,620$6,999,0001.93%
Parallel Advisors, LLC 1,405,895$16,716,0001.35%
Matarin Capital Management, LLC 623,915$7,418,0001.15%
AJ WEALTH STRATEGIES, LLC 668,020$7,943,0001.08%
Capital Impact Advisors, LLC 177,300$2,108,0000.88%
Alambic Investment Management, L.P. 29,547$351,0000.85%
OXFORD FINANCIAL GROUP, LTD. LLC 332,436$3,953,0000.79%
Spark Investment Management LLC 116,400$1,383,0000.74%
View complete list of CORCEPT THERAPEUTICS INC shareholders